The Journal of Organic Chemistry
Article
General Procedure for the Preparation of Fatty Acids 3, 4,
and 7. The corresponding phosphonium salt (0.500 mmol, 1.3 equiv)
was suspended in anhydrous THF (5 mL). NaHMDS (1 M in hexane,
0.96 mmol, 2.5 equiv) was added, and stirring was continued for 15
min at room temperature. The reaction mixture was cooled to −78 °C,
and the corresponding freshly prepared aldehyde (16 or 26,
respectively) (0.384 mmol, 1 equiv), dissolved in anhydrous THF (2
mL), was added slowly. Stirring was continued for 1 h at −78 °C, and
afterward the reaction mixture was allowed to warm to room
temperature for another hour. The reaction was quenched with
formic acid (0.96 mmol, 2.5 equiv) under vigorous stirring, and the
crude product was directly adsorbed on silica gel. After a purification
by means of flash column chromatography (pentane/EtOAc = 20:1,
0.1% of formic acid), the rest of the formic acid in the collected
fractions was quickly removed in high vacuo. The procedure afforded
the respective fatty acids with one (Z)-configured double bond in
yields of 62−65% with a stereochemical purity of 83−86%.
acid (20 mg) was dissolved in THF (0.5 mL), optionally with slight
warming. Hexane (50 mL) was added to yield a homogeneous
suspension. A saturated solution of iodine (6 μL) in hexane was added,
and the apparatus was thoroughly flushed with argon. The reaction
mixture was heated to 60−70 °C for 2 h. Afterward, the solvent was
removed under reduced pressure. Polymerized particles, if they
emerged, were filtrated off. The procedure gave the respective all-
trans fatty acid in 76% to quantitative yield.
(10E,12E,14E,16E,18E)-Tetracosapentaenoic Acid (5). Twenty
milligrams (0.056 mmol) of 3 were subjected to isomerization to yield
15 mg (0.42 mmol, 76%) of 5 as a yellow solid: Rf 0.18 (pentane/
EtOAc = 4:1); 1H NMR (600 MHz, THF-d8) δ 0.88 (t, J = 7.0 Hz, 3
H, 24-H), 1.24−1.36 (m, 12 H, 4-H, 5-H, 6-H, 7-H, 22-H, 23-H), 1.39
(mc, 4 H, 8-H, 21-H), 1.56 (mc, 2 H, 3-H), 2.09 (mc, 4 H, 9-H, 20-H),
2.19 (t, J = 7.5 Hz, 2 H, 2-H), 5.62−5.73 (m, 2 H, 10-H, 19-H), 5.95−
6.35 (m, 8 H, 11-H, 12-H, 13-H, 14-H, 15-H, 16-H, 17-H, 18-H); 13
C
(10Z,12E,14E,16E,18E)-Tetracosapentaenoic Acid (3). 50.0 mg
(0.245 mmol) of 16 was reacted with 163 mg (0.318 mmol) of 17 to
yield 54.5 mg (0.152 mmol, 62%) of 3 in 83% stereochemical purity as
NMR (125 MHz, THF-d8) δ 14.2, 23.3, 25.7, 29.91, 29.99, 29.99,
30.15, 30.19, 30.21, 32.24, 33.60, 33.63, 34.15, 131.80, 131.80, 131.84,
131.86, 133.28, 133.32, 133.67, 133.72, 135.55, 135.59, 174.4; IR
1
(ATR) ν
̃
(cm−1) = 2919, 2849, 1703, 1467, 1435, 1284, 1254, 1221,
a yellow solid: Rf 0.18 (pentane/EtOAc = 4:1); H NMR (300 MHz,
THF-d8) δ 0.88 (t, J = 6.9 Hz, 3 H, 24-H), 1.19−1.47 (m, 16 H, 4-H,
5-H, 6-H, 7-H, 8-H, 21-H, 22-H, 23-H), 1.55 (mc, 2 H, 3-H), 2.09 (mc,
2 H, 20-H), 2.19 (mc, 4 H, 2-H, 9-H), 5.39 (dt, J = 10.6, 7.8 Hz, 1 H,
10-H), 5.69 (dt, J = 14.6, 7.1 Hz, 1 H, 19-H), 5.93−6.36 (m, 7 H, 11-
H, 13-H, 14-H, 15-H, 16-H, 17-H, 18-H), 6.50 (dd, J = 14.1, 11.3 Hz,
1 H, 12-H); 13C NMR (125 MHz, THF-d8) δ 14.3, 23.3, 25.7, 28.6,
29.88, 29.98, 30.04, 30.15, 30.20, 30.5, 32.2, 33.6, 34.1, 128.6, 129.7,
131.63, 131.64, 132.7, 133.2, 133.6, 133.7, 133.9, 135.6, 174.1; IR
1170, 1096; UV (THF) λmax (lg ε) [nm] = 232 (3.81), 304 (4.30), 317
(4.58), 333 (4.77), 350 (4.77); MS (ESI) m/z (%) = 381.3 (100) [M
+ Na]+; HRMS (ESI) calcd for [M + Na]+ (M = C24H38O2) 381.2770,
found 381.2764.
(12E,14E,16E,18E,20E)-Hexacosapentaenoic Acid (6). Twenty
milligrams (0.052 mmol) of 4 were subjected to isomerization to yield
15 mg (0.039 mmol, 76%) of 6 as a yellow solid: Rf 0.18 (pentane/
EtOAc = 4:1); 1H NMR (300 MHz, THF-d8) δ 0.88 (t, J = 6.8 Hz, 3
H, 26-H), 1.24−1.47 (m, 18 H, 4-H, 5-H, 6-H, 7-H, 8-H, 9-H, 10-H,
23-H, 24-H, 25-H), 1.56 (mc, 2 H, 3-H), 2.09 (mc, 4 H, 11-H, 22-H),
2.19 (t, J = 7.5 Hz, 2 H, 2-H), 5.61−5.75 (m, 2 H, 12-H, 21-H), 5.95−
6.27 (m, 8 H, 13-H, 14-H, 15-H, 16-H, 17-H, 18-H, 19-H, 20-H); 13C
NMR (125 MHz, THF-d8) δ 14.2, 23.3, 25.7, 29.9, 29.98, 30.00, 30.16,
30.21, 30.29, 30.30, 30.4, 32.2, 33.6, 33.6, 34.1, 131.63, 131.65, 131.66,
131.69, 133.11, 133.13, 133.50, 133.54, 135.36, 135.41, 174.1; IR
(ATR) ν
̃
(cm−1) = 2919, 2848, 1691, 1466, 1440, 1410, 1318, 1289,
1259, 1226, 1193, 1000; UV (THF) λmax (lg ε) [nm] = 381 (3.26),
352 (4.73), 334 (4.73), 319 (4.53), 305 (4.22), 292 (3.90); MS (ESI)
m/z (%) = 381.3 (100) [M + Na]+; HRMS (ESI) calcd for [M + Na]+
(M = C24H38O2) 381.2770, found 381.2764.
(12Z,14E,16E,18E,20E)-Hexacosapentaenoic Acid (4). 50.0 mg
(0.245 mmol) of 16 was reacted with 172 mg (0.318 mmol) of 18 to
yield 61.6 mg (0.159 mmol, 65%) of 4 in 85% stereochemical purity as
1
(ATR) ν
̃
(cm−1) = 2914, 2848, 1706, 1467, 1434, 1305, 1273, 1245,
a yellow solid: Rf 0.18 (pentane/EtOAc = 4:1); H NMR (300 MHz,
THF-d8) δ 0.88 (t, J = 6.9 Hz, 3 H, 26-H), 1.20−1.47 (m, 20 H, 4-H,
5-H, 6-H, 7-H, 8-H, 9-H, 10-H, 21-H, 22-H, 23-H), 1.55 (mc, 2 H, 3-
H), 2.09 (mc, 2 H, 22-H), 2.19 (mc, 4 H, 2-H, 11-H), 5.40 (dt, J =
10.6, 7.8 Hz, 1 H, 12-H), 5.69 (dt, J = 14.6, 7.1 Hz, 1 H, 21-H), 5.93 -
6.36 (m, 7 H, 13-H, 15-H, 16-H, 17-H, 18-H, 19-H, 20-H), 6.50 (dd, J
= 14.1, 11.3 Hz, 1 H, 14-H); 13C NMR (125 MHz, THF-d8) δ 14.3,
23.3, 25.7, 28.6, 29.9, 30.0, 30.1, 30.2, 30.33, 30.33, 30.4, 30.5, 32.2,
33.6, 34.1, 128.6, 129.7, 131.63, 131.63, 132.7, 133.2, 133.6, 133.7,
1218, 1189, 1001; UV (THF) λmax (lg ε) = 350 nm (4.82), 332 (4.82),
317 (4.62), 304 (3.37); MS (ESI) m/z (%) = 409.3 (99) [M + Na]+;
HRMS (ESI) calcd for [M + Na]+ (M = C26H42O2) 409.3083, found
409.3077.
(8E,10E,12E,14E,16E,18E)-Tetracosahexaenoic Acid (8).
Twenty milligrams (0.056 mmol) of 7 were subjected to isomerization
to yield 20 mg (0.056 mmol, 100%) of 8 as a yellow solid: Rf 0.18
(pentane/EtOAc = 4:1); 1H NMR (300 MHz, THF-d8) δ 0.89 (t, J =
6.9 Hz, 3 H, 24-H), 1.24−1.49 (m, 12 H, 4-H, 5-H, 6-H, 21-H, 22-H,
23-H), 1.57 (mc, 2 H, 3-H), 2.10 (mc, 4 H, 7-H, 20-H), 2.19 (mc, 2 H,
2-H), 5.69 (dt, J = 14.1, 7.2 Hz, 2 H, 8-H, 19-H), 5.96−6.36 (m, 10 H,
9-H, 10-H, 11-H, 12-H, 13-H, 14-H, 15-H, 16-H, 17-H, 18-H); 13C
NMR (125 MHz, THF-d8) δ 14.2, 23.2, 25.7, 29.7, 29.8, 29.9, 30.0,
32.2, 33.50, 33.53, 34.1, 131.67, 131.70, 131.70, 131.70, 133.15,
133.17, 133.51, 133.55, 133.79, 133.83, 135.52, 135.55, 174.0; IR
133.9, 135.6, 174.1; IR (ATR) ν
̃
(cm−1) = 2918, 2848, 1692, 1466,
1437, 1410, 1296, 1273, 1244, 1216, 1189, 1001; UV (THF) λmax (lg
ε) [nm] = 352 (4.86), 334 (4.87), 319 (4.65), 305 (4.33); MS (ESI)
m/z (%) = 409.4 (98) [M + Na]+; HRMS (ESI) calcd for [M + Na]+
(M = C26H42O2) 409.3083, found 409.3077.
(8Z,10E,12E,14E,16E,18E)-Tetracosahexaenoic Acid (7). 50.0
mg (0.217 mmol) of 26 was reacted with 137.0 mg (0.282 mmol) of
20 to yield 48.7 mg (0.137 mmol, 63%) of 7 in 86% stereochemical
1
(ATR) ν
̃
(cm−1) = 2954, 2916, 2847, 1693, 1466, 1432, 1305, 1280,
purity as a yellow solid: Rf 0.18 (pentane/EtOAc = 4:1); H NMR
(300 MHz, THF-d8) δ 0.89 (t, J = 6.9 Hz, 3 H, 24-H), 1.24−1.47 (m,
12 H, 4-H, 5-H, 6-H, 21-H, 22-H, 23-H), 1.57 (mc, 2 H, 3-H), 2.10
(mc, 2 H, 20-H), 2.20 (mc, 4 H, 2-H, 7-H), 5.41 (dt, J = 10.6, 7.7 Hz, 1
H, 8-H), 5.70 (dt, J = 14.5, 7.2 Hz, 1 H, 19-H), 5.94−6.40 (m, 9 H, 9-
H, 11-H, 12-H, 13-H, 14-H, 15-H, 16-H, 17-H, 18-H), 6.53 (dd, J =
13.6, 11.5 Hz, 1 H, 10-H); 13C NMR (125 MHz, THF-d8) δ 14.2,
23.3, 25.7, 28.5, 29.7, 29.8, 29.9, 30.3, 32.2, 33.6, 34.1, 128.9, 129.8,
131.66, 131.67, 132.8, 133.1, 133.6, 133.67, 133.74, 133.9, 134.0,
1237, 1201, 1000; UV (THF) λmax (lg ε) [nm] = 405 (3.90), 379
(5.01), 359 (4.99), 341 (4.76), 326 (4.43), 310 (4.04); MS (ESI) m/z
(%) = 379.3 (100) [M + Na]+; HRMS (ESI) calcd for [M − H]− (M
= C24H36O2) 355.2643, found 355.2646.
General Procedure for the Activation with Pentafluorophe-
nol. Pentafluorophenol (48 mg, 0.26 mmol, 1.3 equiv) and Hunig’s
̈
base (44 μL, 0.26 mmol, 1.3 equiv) were dissolved in anhydrous
dichloromethane (3 mL) and added as a solution to any fatty acid
(0.20 mmol, 1 equiv). EDCI·HCl (50 mg, 0.26 mmol, 1.3 equiv) was
added at once, and stirring was continued at room temperature for 2 h.
The reaction mixture was diluted with diethylether (20 mL) and
washed three times with brine. A separation of the organic phase,
drying over Na2SO4, and removal of solvent under reduced pressure
gave the activated fatty acid as crude product in 95% yield.
135.7, 174.1; IR (ATR) ν
̃
(cm−1) = 2953, 2921, 2852, 1691, 1463,
1433, 1411, 1281, 1231, 1197, 1001; UV (THF) λmax (lg ε) [nm] =
405 (3.72), 381 (4.86), 360 (4.85), 343 (4.64), 327 (4.35), 310 (4.00);
MS (ESI) m/z (%) = 379.3 (96) [M + Na]+; HRMS (ESI) calcd for
[M − H]− (M = C24H36O2) 355.2643, found 355.2643.
General Procedure for the Isomerization of Fatty Acids 3, 4,
and 7 to the Corresponding all-(E) Species 5, 6, and 8. The fatty
5303
dx.doi.org/10.1021/jo300624h | J. Org. Chem. 2012, 77, 5297−5304